Clay–polymer nanocomposites as a novel drug carrier: Synthesis, characterization and controlled release study of Propranolol Hydrochloride
Authors:
- SeemaSESeema
- Monika DattaMDMonika Datta
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Applied Clay Science
- Vol. 80-81, 85-92
Abstract
No abstract availableKeywords
Funding Information
- UGC/RGNF (sch/rgnf/srf/f-10/2007-08)
This publication has 27 references indexed in Scilit:
- Hybrid materials based on montmorillonite and citostatic drugs: Preparation and characterizationApplied Clay Science, 2011
- Tramadol hydrochloride/montmorillonite composite: Preparation and controlled drug releaseApplied Clay Science, 2010
- Floating Matrix Dosage Form for Propranolol Hydrochloride Based on Gas Formation Technique: Development and In Vitro EvaluationScientia Pharmaceutica, 2010
- Montmorillonite intercalated with vitamin B1 as drug carrierApplied Clay Science, 2009
- Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of DocetaxelBiomaterials, 2009
- Montmorillonite as a drug delivery system: Intercalation and in vitro release of timolol maleateInternational Journal of Pharmaceutics, 2009
- Use of clays as drug delivery systems: Possibilities and limitationsApplied Clay Science, 2007
- Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochlorideInternational Journal of Pharmaceutics, 2006
- Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials, 2005
- Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis, 2003